Peter Attia· MD
and on pro mcts if it's not specifically more so likely in people without the e4 variant there's more window or more leeway to be able to use them but mct is is a really tricky topic but i personalize mct use based on this
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and on pro mcts if it's not specifically more so likely in people without the e4 variant there's more window or more leeway to be able to use them but mct is is a really tricky topic but i personalize mct use based on this
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
So the finding was in that study, which is relatively small, that at least not with the diet, but using a ketone supplement that was formulated with 20 grams of medium-chain triglycerides. So they gave to their patients, I think, just once a day. And they did show fairly convincingly that the elevation of beta-hydroxybutyrate correlated with an improvement in cognitive function, but that correlation was not observed in the ApoE4 positive group, which was a little bit...it was kind of surprising.